The Drugs Controller General of India (DCGI) approved the two vaccines Covaxin and Corbevax for children under 12 in India, against the Wuhan Virus, also known as the Novel Coronavirus (COVID-19.)
While the Hyderabad based Bharat Biotech International Private Limited manufactured Covaxin has been approved for 6 to12-year-old children, the Biological E manufactured Corbevax would be used as Emergency Use Authorization (EUA) for 5 to12 year-old kids in India.
The approval was based on the Subject Expert Committee’s recommendation report, which was prepared as per trials of the vaccines.
As per sources, he Subject Expert Committee (SEC) or the Drugs Controller General of India (DCGI) recommended the Corbevax COVID-19 vaccine for children between the 5 to 12-year-old age group. On April 21, the government panel said the vaccine is effective in children and has been recommended after trials.
After studying the recommendations of the SEC, the DCGI approved the two vaccines for children.
Meanwhile, Biological E’s Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years. Covaxin has been granted Emergency Use Listing (EUL) by the DCGI for the age group of 12 to 18 years on December 24, 2021.
Mango News Link
Telegram: https://t.me/mangonewsofficial
Google Play Store: https://bit.ly/2R4cbgN
Apple / iOS Store: https://apple.co/2xEYFJ
